This site is intended for healthcare professionals only
LoginRegister
Lupin to Conduct BE Study for Synthetic Semaglutide Tablets in 3 StrengthsLupin carves out consumer healthcare business
USFDA approves Takeda Gammagard liquid ERC for primary immunodeficiencyUSFDA approves Takeda Gammagard liquid ERC for primary immunodeficiency
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationHPV9 vaccine: Biological E to get exclusive right to commercialize REC603 in India
Aurobindo Pharma restarts production at Kakinada Penicillin-G plant after fire incidentAurobindo Pharma arm restarts production at Kakinada Penicillin-G plant after fire incident
Girl With Fever Given Rabies Vaccine, Probe OrderedAlembic Pharma bags USFDA nod for cancer injection Doxorubicin Hydrochloride Liposome
Sanofi earns orphan drug designation for multiple myeloma drugSanofi Riliprubart receives orphan drug designation in Japan for chronic inflammatory demyelinating...
Hetero Labs Acarbose-Sitagliptin-Metformin FDC Rejected by CDSCO Panel Over GI RiskHetero Labs' Acarbose-Sitagliptin-Metformin FDC Rejected by CDSCO Panel Over GI Risk
JB Chemicals Panoli facility concludes USFDA inspection no observationsAfter Much Tussle, Torrent Pharma Clinches JB Chemicals Deal at Rupees 25,689 Crore Valuation
Biocon, NCSM partnerBiocon Biologics Expands Insulin Access in Malaysia
Precigen secures full USFDA nod for Papzimeos for adults with Recurrent Respiratory PapillomatosisUS FDA eliminates risk evaluation, mitigation strategies for CAR-T cancer therapies
CDSCO Clears Abbotts phase IV Trial Of Dydrogesterone MR TabletCDSCO Clears Abbott's phase IV Trial Of Dydrogesterone MR Tablet
UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorderUCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder
X